<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon

Default sub title

minute read

by The New York Times | April 22, 2021
placeholder

Federal health officials are leaning toward lifting their recommended pause on the use of Johnson & Johnson’s coronavirus vaccine after finding only a limited number of additional cases of a rare blood clotting disorder among recipients.

Topics: Press Coverage